Milestone Pharmaceuticals Inc.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Milestone Pharmaceuticals Inc..The latest application filed is for "highly water-soluble salts of a short acting phenylalkylamine calcium channel blocker and uses thereof".

Company Profile

8.14.23

Milestone Pharmaceuticals Inc. - Saint-Laurent CA
Milestone Pharmaceuticals Inc. - Montreal Quebec CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Highly Water-soluble Salts Of A Short Acting Phenylalkylamine Calcium Channel Blocker And Uses Thereof App 20220296556 - MAGUIRE; Martin P.	2022-09-22
Short Acting Phenylalkylamine Calcium Channel Blockers And Uses Thereof App 20220142963 - MAGUIRE; Martin P. ; et al.	2022-05-12
Highly Water-soluble Salts Of A Short Acting Phenylalkylamine Calcium Channel Blocker And Uses Thereof App 20220040139 - MAGUIRE; Martin P.	2022-02-10
Short Acting Phenylalkylamine Calcium Channel Blockers And Uses Thereof App 20210315855 - MAGUIRE; Martin P. ; et al.	2021-10-14
Highly Water-soluble Salts Of A Short Acting Phenylalkylamine Calcium Channel Blocker And Uses Thereof App 20210205258 - MAGUIRE; Martin P.	2021-07-08
Short Acting Phenylalkylamine Calcium Channel Blockers And Uses Thereof App 20210059972 - MAGUIRE; Martin P. ; et al.	2021-03-04
Highly Water-soluble Salts Of A Short Acting Phenylalkylamine Calcium Channel Blocker And Uses Thereof App 20200368195 - MAGUIRE; Martin P.	2020-11-26
Short Acting Phenylalkylamine Calcium Channel Blockers And Uses Thereof App 20200230097 - MAGUIRE; Martin P. ; et al.	2020-07-23
Highly Water-soluble Salts Of A Short Acting Phenylalkylamine Calcium Channel Blocker And Uses Thereof App 20200121631 - Maguire; Martin P.	2020-04-23
Short Acting Phenylalkylamine Calcium Channel Blockers And Uses Thereof App 20190380993 - MAGUIRE; Martin P. ; et al.	2019-12-19
Highly Water-soluble Salts Of A Short Acting Phenylalkylamine Calcium Channel Blocker And Uses Thereof App 20190269643 - MAGUIRE; Martin P.	2019-09-05
Short Acting Phenylalkylamine Calcium Channel Blockers And Uses Thereof App 20190142781 - MAGUIRE; Martin P. ; et al.	2019-05-16
Highly Water-soluble Salts Of A Short Acting Phenylalkylamine Calcium Channel Blocker And Uses Thereof App 20190022048 - MAGUIRE; Martin P.	2019-01-24
Highly water-soluble salts of a short acting phenylalkylamine calcium channel blocker and uses thereof Grant 10,117,848 - Maguire November 6, 2	2018-11-06
Short Acting Phenylalkylamine Calcium Channel Blockers And Uses Thereof App 20180280339 - MAGUIRE; Martin P. ; et al.	2018-10-04
Short acting phenylalkylamine calcium channel blockers and uses thereof Grant 10,010,524 - Maguire , et al. July 3, 2	2018-07-03
Short acting phenylalkylamine calcium channel blockers and uses thereof Grant 10,010,523 - Maguire , et al. July 3, 2	2018-07-03
Short acting phenylalkylamine calcium channel blockers and uses thereof Grant 10,010,522 - Maguire , et al. July 3, 2	2018-07-03
Highly Water-soluble Salts Of A Short Acting Phenylalkylamine Calcium Channel Blocker And Uses Thereof App 20180110752 - MAGUIRE; Martin P.	2018-04-26
Short Acting Phenylalkylamine Calcium Channel Blockers And Uses Thereof App 20170312241 - MAGUIRE; Martin P. ; et al.	2017-11-02
Short Acting Phenylalkylamine Calcium Channel Blockers And Uses Thereof App 20170312243 - MAGUIRE; Martin P. ; et al.	2017-11-02
Short Acting Phenylalkylamine Calcium Channel Blockers And Uses Thereof App 20170312242 - MAGUIRE; Martin P. ; et al.	2017-11-02
Short acting phenylalkylamine calcium channel blockers and uses thereof Grant 9,737,503 - Maguire , et al. August 22, 2	2017-08-22
Short Acting Phenylalkylamine Calcium Channel Blockers And Uses Thereof App 20160374982 - MAGUIRE; Martin P. ; et al.	2016-12-29
Short acting phenylalkylamine calcium channel blockers and uses thereof Grant 9,463,179 - Maguire , et al. October 11, 2	2016-10-11
Short Acting Phenylalkylamine Calcium Channel Blockers And Uses Thereof App 20160074354 - MAGUIRE; Martin P. ; et al.	2016-03-17
Short acting phenylalkylamine calcium channel blockers and uses thereof Grant 9,227,918 - Maguire , et al. January 5, 2	2016-01-05
Short Acting Phenylalkylamine Calcium Channel Blockers And Uses Thereof App 20140296335 - MAGUIRE; Martin P. ; et al.	2014-10-02
Short acting benzothiazepine calcium channel blockers and uses thereof Grant 8,501,727 - Maguire , et al. August 6, 2	2013-08-06
Short Acting Benzothiazepine Calcium Channel Blockers And Uses Thereof App 20110144087 - Maguire; Martin P. ; et al.	2011-06-16
Short Acting Phenylalkylamine Calcium Channel Blockers And Uses Thereof App 20100190852 - Maguire; Martin P. ; et al.	2010-07-29

Company Registrations

SEC

0001408443

Milestone Pharmaceuticals Inc. of QUEBEC, CANADA

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.